EBITA grew 37% y-o-y Sees positive signals in the Swedish project market Trading at 9x '25e EV/EBITA...
Beat on adj. EBIT but lower OCF Adj. EBIT up 8.9-9.
Q4 better than expected, adj. EBITA +0-2% Financial flexibility for divi, buybacks & M&A with curren...
Q4 report due on 21 February Q4e sales: EUR 47m, order intake: EUR 43m Several orders announced duri...
Tough end to 2024 Market to turn positive in '25e, according to report Re-setting expectation, '25e ...
CapMan reports Q4 results on February 13th. Fundraising activities are of more interest, with financ...
Stronger end to Q4 vs the PW in Dec Adj. EBITA 18% higher than guided for Estimates up slightly toda...
Adj. EBIT +85% vs ABGSCe Soft cash flow generation Estimates likely up 10% on adj.
Hyresintäkterna steg till 3 438 (3 366) mkr, varav 861 (827) mkr i det fjärde kvartalet.
Redeye will likely retain its view of Hanza following a Q4 report with sales and EBITA slightly belo...
In our view, earnings will become more stable, as the company seems satisfied with its structure aft...
We cut '25e-'26e adj. EBITA by 10-1% Utilisation should pick up in H2'25e '25e EV/EBITA of ~8x What...
Solteq reports Q4’24 results on Thursday, February 13th.
Redeye gives a short comment on the news that Saniona’s partner Medix will file a final version of T...
Weak order trend broken, orders +29% y-o-y, above our flat estimate '25e-'26e orders +7%, sales +4%,...
